Repair of O6-alkylguanine by alkyltransferases

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 83-100

  Pegg, Anthony E ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Alkylation damage repair; Alkyltransferase; Chemotherapy; O6 Benzylguanine; O6 Methylguanine

Indexed keywords

6 O BENZYLGUANINE; 6 O METHYLGUANINE; ALKYLATING AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; METHYLNITROSOUREA; NIMUSTINE; SEMUSTINE; TEMOZOLOMIDE; TRANSFERASE;

CANCER CHEMOTHERAPY; CARCINOGENESIS; CYTOTOXICITY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; ENZYME ACTIVITY; ENZYME REGULATION; MUTATION; PRIORITY JOURNAL; REVIEW;

MAMMALIA; MUS MUSCULUS;

EID: 0034028030     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00017-X     Document Type: Article

References (151)

1. Lindahl T., Sedgwick B., Sekiguchi M., Nakabeppu Y. Regulation and expression of the adaptive response to alkylating agents. Annu. Rev. Biochem. 57:1988;133-157.
2. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenesis and therapeutic agents. Cancer Res. 50:1990;6119-6129.
3. 6-alkylguanine. FASEB J. 6:1992;2302-2310.
4. Mitra S., Kaina B. Regulation of repair of alkylation damage in mammalian genomes. Prog. Nucleic Acid Res. Mol. Biol. 44:1993;109-142.
5. 6-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 51:1995;167-223.
6. Sekiguchi M., Sakumi K. Roles of DNA repair methyltransferase in mutagenesis and carcinogenesis. Jpn. J. Hum. Genet. 42:1997;389-399.
7. 6-methylguanine-DNA methyltransferase expression. Pharmacol. Ther. 74:1997;285-297.
8. 6-methylguanine-DNA methyltransferase from E. coli. EMBO J. 13:1994;1495-1501.
9. Parikh S.S., Mol C.D., Slupphaug G., Bharati S., Krokan H.E., Tainer J.A. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J. 17:1998;5214-5226.
10. Roberts R.J., Cheng X. Base flipping. Annu. Rev. Biochem. 67:1998;181-198.
11. 6-methylguanine-DNA methyltransferase binds DNA. Proteins. 32:1998;3-6.
12. 6-benzylguanine. Biochemistry. 34:1995;7113-7119.
13. 6-alkylguanine-DNA alkyltransferase. Biochemistry. 37:1998;12489-12495.
14. 6-benzylguanine, Biochem. J. (2000) in press.
15. 6-alkylguanine-DNA alkyltransferase. Mutat. Res. 363:1996;15-25.
16. 6-alkylguanine-DNA alkyltransferase. Biochemistry. 38:1999;6801-6806.
17. Christians F.C., Loeb L.A. Novel human DNA alkyltransferases obtained by random substitution and genetic selection in bacteria. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6124-6128.
18. 6-benzylguanine. Cancer Res. 59:1998;1936-1945.
19. 6-alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context. Nucleic Acids Res. 24:1996;2087-2094.
20. Kamath-Loeb A.S., Hizi A., Tabone J., Solomon M.S., Loeb L.A. Inefficient repair of RNA·DNA hybrids. Eur. J. Biochem. 1997:1997;492-501.
21. 4MeT from nucleotide excision repair. Carcinogenesis. 18:1997;919-924.
22. 4-methylthymine with similar efficiency. Biochemistry. 36:1997;11118-11124.
23. 6-alkylguanine-DNA alkyltransferase in E. coli increases cell killing and mutations by N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 20:1999;103-108.
24. 6-alkylguanine-DNA alkyltransferase cDNA. Nucleic Acids Res. 27:1999;1795-1801.
25. 4-methylthymine in DNA. Carcinogenesis. 16:1995;1595-1602.
26. 4-methylthymine in Escherichia coli using double-stranded and gapped plasmids. Carcinogenesis. 19:1998;457-461.
27. 6-Benzylguanine and its role in chemotherapy. Clin. Cancer Res. 3:1997;837-847.
28. 6-alkylguanine-DNA alkyltransferase. J. Biol. Chem. 272:1997;8332-8339.
29. 6-benzylguanine in oligodeoxyribonucleotides. J. Biol. Chem. 273:1998;10863-10867.
30. 6-Alkylguanine-DNA Alkyltransferase as a Target for Cancer Chemotherapy, in: M. Ehrlich (Ed.), DNA Alterations in Cancer: Genetic and Epigenetic Changes. BioTechniques Books, Eaton Publ., Natick, MA, 2000, pp. 471-488.
31. 6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)-(benzyloxy)-2,6(4)-diamino-5-(nitro or nitroso)pyrimidine derivatives and analogues. J. Med. Chem. 41:1998;503-508.
32. 6-(hetarylmethyl)guanines having basic rings in the side chain. J. Med. Chem. 41:1998;5265-5271.
33. 6-benzylguanine derivatives. Biochem. Pharmacol. 53:1997;1559-1564.
34. 6-benzylguanine derivatives in oligodeoxynucleotides. Chem. Res. Toxicol. 10:1997;1234-1239.
35. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 10:1997;562-567.
36. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 12:1999;127-131.
37. Mackay W.J., Han S., Samson L.D. DNA alkylation repair limits spontaneous base substitution mutations in Escherichia coli. J. Bacteriol. 176:1994;3224-3230.
38. 6-ethylguanine in DNA. Nucleic Acids Res. 22:1994;1613-1619.
39. 6-benzylguanine using a transgenic model. Cancer Res. 56:1996;1880-1885.
40. 6-methylguanine-DNA methyltransferase. Biochemistry. 36:1997;5769-5776.
41. 6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis. Pharmacogenetics. 6:1996;361-363.
42. 6-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site region. Pharmacogenetics. 9:1999;81-87.
43. 6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis. 16:1995;2441-2445.
44. 6-8-oxo-benzylguanine. Biochem. Pharmacol. 58:1999;237-244.
45. 6-benzylguanine. Biochem. Pharmacol. 58:1999;1279-1285.
46. 6-benzylguanine. Clin. Cancer Res. 5:1999;521-524.
47. 6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin. Cancer Res. 55:1999;209-213.
48. 6-alkylguanine DNA alkyltransferase codons 143 and 160 polymorphisms in lung cancer risk. Proc. Am. Assoc. Cancer Res. 40:1999;A1646.
49. 6-methylguanine DNA methyltransferase gene in human melanoma. Proc. Am. Assoc. Cancer Res. 40:1999;A3093.
50. 6-methylguanine-DNA methyltransferase gene in esophageal cancer tissues from northern China. Int. J. Cancer. 71:1997;719-723.
51. 6-methlyguanine-DNA methyltransferase are both required for its nuclear localization. EMBO J. 15:1996;4050-4060.
52. 6-methylguanine lesion. Mol. Cell Biol. 18:1998;1660-1669.
53. 6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts. Mutat. Res. 250:1991;397-409.
54. 6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1635-1640.
55. 6-benzylguanine or 1,3 bis(2-chloroethyl)-1-nitrosourea. Biochemistry. 35:1996;1328-1334.
56. 6-methylguanine in non-tumour derived human cell and tissue extracts. Biochem. Soc. Trans. 25:1997;3595.
57. 6-benzylguanine. Proc. Am. Assoc. Cancer Res. 40:1999;A2656.
58. 6-methylguanine in hepatocellular carcinogenesis. J. Hepatic, Biliary, Pancreatic Surg. 5:1998;355-366.
59. 6-methylguanine-DNA methyltransferase upon alkylation of its active site by SN1 (indirect-acting) and SN2 (direct acting) alkylating agents: breaking a "salt-link"? Biochemistry. 35:1996;12259-12266.
60. 145 mutant AGT: comparison by isoelectric focusing, CD and time-resolved fluorescence spectroscopy. Biochem. J. 324:1997;321-328.
61. 6-alkylguanine-DNA alkyltransferase protein in its alkylated and DNA bound states by limited proteolysis. Biochem. J. 329:1998;545-550.
62. 6-alkylguanine-DNA alkyltransferase, unpublished observations (1999).
63. Pletsa V., Steenwinkle M.J.S.T., van Delft J.H.M., Baan R.A., Kyrtopolous S.A. Methyl bromide causes DNA methylation in rats and mice but fails to induce somatic mutations in λlacZ transgenic mice. Cancer Lett. 135:1999;21-27.
64. 6-Methylguanine-DNA methyltransferase activity in human buccal mucosal tissue and cell cultures. Complex mixtures related to habitual use of tobacco and betel quid inhibit the activity in vitro. Carcinogenesis. 18:1997;1889-1895.
65. 6-alkylguanine DNA alkyltransferase activity in student embalmers. Am. J. Ind. Med. 31:1997;361-365.
66. 6-methylguanine DNA methyltransferase in mononuclear blood cells of formaldehyde-exposed medical students. Arch. Toxicol. 73:1999;15-21.
67. 6-methylguanine in mammalian cells. Arch. Toxicol. 72:1998;681-689.
68. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6941-6946.
69. 6-Methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res. 58:1998;1068-1073.
70. 6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis. 19:1998;1247-1250.
71. 6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells. Anticancer Res. 17:1997;4311-4316.
72. Iwakuma T., Shiraishi A., Fukuhara M., Kawate H., Sekiguchi M. Organization and expression of the mouse gene for DNA repair methyltransferase. DNA Cell Biol. 15:1996;863-872.
73. 6-methylguanine-DNA methyltransferase associated with resistance to alkylating drugs in a mammalian cell line. J. Biol. Chem. 272:1997;13250-13254.
74. 6-methylguanine-DNA methyltransferase via protein kinase C-mediated signalling. Cancer Res. 58:1998;3950-3956.
75. 6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4348-4353.
76. 6-methylguanine-DNA methyltransferase gene. Cancer Res. 56:1996;2029-2032.
77. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene. 17:1998;845-851.
78. 6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. Oncogene. 12:1996;693-697.
79. 6-methylguanine-DNA methyltransferase activity in mouse astrocytes. Carcinogenesis. 20:1999;2361-2365.
80. 6-methylguanine-DNA methyltransferase gene. Cancer Res. 57:1997;3672-3677.
81. 6-methylguanine-DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell Biol. 17:1997;5612-5619.
82. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol. Carcinog. 24:1999;85-89.
83. Herfath L.K.F., Brent T.P., Danam R.P., Remack J.S., Kodner I.J., Wells J., Goodfellow S.A., Goodfellow P.J. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol. Carcinog. 24:1999;90-98.
84. 6-Alkylguanine-DNA alkyltransferase in normal colon tissue and colon cancer. Oncol. Res. 9:1997;149-153.
85. Sekiguchi M., Nakabeppu Y., Sakumi K., Tuzuki T. DNA-repair methyltransferase as a molecular device for preventing mutation and cancer. J. Cancer Res. Clin. Oncol. 122:1996;199-206.
86. Zaidi N.H., Pretlow T.P., O'Riordan M.A., Dumenco L.L., Allay E., Gerson S.L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis. 16:1995;451-456.
87. Liu L., Qin X., Gerson S.L. Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis. 20:1999;279-284.
88. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage-skin carcinogenesis. Cancer Res. 56:1996;3244-3249.
89. 6-alkylguanine DNA-alkyltransferase. Oncogene. 15:1998;2127-2132.
90. Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., Sekiguchi M. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis. 18:1997;1631-1635.
91. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 57:1997;2415-2418.
92. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., Takano H., Noda T., Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5116-5120.
93. 6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea. Cancer Res. 57:1997;3335-3338.
94. 6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. Mol. Pharmacol. 52:1997;249-258.
95. Tominaga Y., Tsuzuki T., Shiraishi A., Kawate H., Sekiguchi M. Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. Carcinogenesis. 18:1997;889-896.
96. 6-Alkylguanine DNA lesions trigger apoptosis. Carcinogenesis. 19:1998;369-372.
97. Karran P., Hampson R. Genomic instability and tolerance to alkylating agents. Cancer Surv. 28:1996;69-85.
98. D'Atri S., Tentori L., Lacal P.M., Graziani G., Pagani E., Benincasa E., Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol. 54:1998;334-341.
99. Toft N.J., Winton D.J., Kelly J., Howard L.A., Dekker M., Te Riele H., Arends M.J., Wyllie A.H., Margison G.P., Clarke A.R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3911-3915.
100. Tentori L., Lacal P.M., Benincasa E., Franco D., Faraoni I., Bonmassar E., Graziani G. Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase. J. Pharmacol. Exp. Ther. 285:1998;884-893.
101. Humbert O., Siumicino S., Aquilina A., Branch P., Oda S., Zijno A., Karran P., Bignami M. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents. Carcinogenesis. 20:1999;205-214.
102. + and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat. Res. 381:1997;227-241.
103. Kaina B. Critical steps in alkylation-induced aberration formation. Mutat. Res. 404:1998;119-124.
104. Armstrong M.J., Galloway S.M. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. Mutat. Res. 373:1997;167-178.
105. Greenwood S.K., Armstrong M.J., Hill R.B., Bradt C.I., Johnson T.E., Hilliard C.A., Galloway S.M. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Mutat. Res. 401:1998;39-53.
106. Peták I., Mihalik R., Bauer P.I., Süli-Vargha H., Sebestyén A., Kopper L. BCNU is a caspase-mediated inhibitor of drug-induced apoptosis. Cancer Res. 58:1998;614-618.
107. 6-benzyl-2′-deoxyguanosine and BCNU. Cancer Res. 56:1996;2076-2081.
108. Aquilina G., Ceccotti S., Martinelli S., Hampson R., Bignami M. N-(2-Chloroethyl)-N′-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 58:1998;135-141.
109. 6-alkylguanine-DNA alkyltransferase and N,N-bis(2-chloroethyl)-N-nitrosourea. Biochem. Pharmacol. 50:1995;1141-1148.
110. 6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J. Clin. Oncol. 16:1998;3310-3315.
111. 6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients. Can. J. Neurol. Sci. 26:1999;104-109.
112. 6-Methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Clin. Cancer Res. 5:1999;807-814.
113. Citti L., Eckstein F., Capecchi B., Mariani L., Nevischi S., Poggi A., Rainaldi G. Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide. Antisense Nucleic Acid Drug Dev. 9:1999;125-133.
114. + transfected cells to mitozolomide. Carcinogenesis. 17:1996;25-29.
115. 6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas. Neurosurgery. 41:1997;434-441.
116. Dolan M.E. Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents. Adv. Drug Delivery Rev. 26:1997;105-118.
117. 6-benzylguanine for patients undergoing surgery for malignant glioma. J. Clin. Oncol. 16:1998;3570-3575.
118. 6-Benzylguanine in humans: metabolic, pharmacokinetic and pharmacodynamic findings. J. Clin. Oncol. 16:1998;1803-1810.
119. 6-Benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res. 59:1999;2402-2410.
120. 6-benzylguanines. Effect of metabolism. Cancer Chemother. Pharmacol. 45:2000;69-77.
121. 6-(Alkyl/aralkyl)guanosine and 2′-deoxyguanosine derivatives: synthesis and ability to enhance chloroethylnitrosourea antitumor action. J. Med. Chem. 40:1997;2902-2909.
122. 2-acetylguanosine. Melanoma Res. 8:1998;123-130.
123. 6-benzylguanine. Proc. Am. Assoc. Cancer Res. 40:1999;A39.
124. 6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother. Pharmacol. 40:1997;266-272.
125. Friedman H.S., McLendon R.E., Dolan M.E., Pegg A.E., Moschel R.C., Colvin O.M., Cokgor I., Friedman A.H., Schold S.C., Bigner D.D., Modrich P.L. The biology of sensitivity and resistance to the molecule (temozolomide). Proc. Am. Assoc. Cancer Res. 40:1999;754-755.
126. 6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br. J. Cancer. 78:1998;1199-1202.
127. 6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas. Lab. Invest. 78:1998;643-644.
128. Case M.C., Burt A.D., Hughes J., Palmer J.M., Collier J.D., Bassendine M.F., Yeaman S.J., Hughes M.A., Major G.N. Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. J. Immunol. Methods. 223:1999;93-106.
129. 6-benzylguanine plus BCNU. Cancer Res. 57:1997;4817-4823.
130. 6-Benzylguanine-mediated enhancement of nitrosourea activity in Mer minus central nervous system tumor xenografts - implications for clinical trials, Cancer Chemother. Pharmacol. (2000) in press.
131. 6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells. J. Biol. Chem. 272:1997;28596-28606.
132. 6-benzylguanine. Cancer Res. 59:1999;1514-1519.
133. 6-benzylguanine, Biochem. J. (2000) in press.
134. Encell L.P., Coates M.M., Loeb L.A. Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis. Cancer Res. 58:1998;1013-1020.
135. 6-benzylguanine. Cancer Res. 57:1997;2007-2012.
136. 6-benzylguanine to killing by N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res. 56:1996;1578-1583.
137. 6-benzylguanine sensitization to chloroethylnitrosourea treatment. J. Pharmacol. Exp. Ther. 290:1999;1467-1474.
138. 6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol. 39:1997;307-316.
139. 6-Alkylguanine-DNA alkyltransferase
140. 6-methylguanine DNA methyltransferase complementary DNA. J. Immunol. 158:1997;1006-1013.
141. Kleibl K., Margison G.P. Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy. Neoplasma. 45:1998;181-186.
142. 6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1. Mutat. Res. 401:1998;133-141.
143. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 57:1997;5093-5099.
144. 6-alkylguanine-DNA alkyltransferase. Gene Ther. 5:1998;842-847.
145. 6-benzylguanine and BCNU and allows intensive therapy of BCNU resistant human colon cancer xenografts. Hum. Gene Ther. 10:1999;1021-1030.
146. 6-benzylguanine and temozolomide. Clin. Cancer Res. 5:1999;163-169.
147. Hansen W.K., Deutsch W.A., Yacoub A., Xu Y., Williams D.A., Kelley M.R. Creation of a fully functional human chimeric DNA repair protein. J. Biol. Chem. 273:1998;756-762.
148. 6-Methylguanine-DNA methyltransferease activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int. J. Cancer. 77:1998;919-922.
149. 6-alkylguanine-DNA alkyltransferase. Cancer Chemother. Pharmacol. 43:1999;80-85.
150. 6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene. 18:1999;525-532.
151. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary neoplasia. Cancer Res. 59:1999;793-797.